Total Number Of Voting Rights And Share Capital In Novo Nordisk A/S As Of 28 April 2017

Bagsværd, Denmark, 28 April 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.

Further information

Media:
Anne Margrethe Hauge+45 3079 3450amhg@novonordisk.com

Investors:
Peter Hugreffe Ankersen+45 3075 9085phak@novonordisk.com
Hanna Ögren+45 3079 8519haoe@novonordisk.com
Anders Mikkelsen+45 3079 4461armk@novonordisk.com
Kasper Veje (US)+1 609 235 8567kpvj@novonordisk.com
Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/5fa67bf8-96e5-4cc1-871f-1625c70ddfd4

Back to news